Recent advances and novel treatment paradigms in acute lymphocytic leukemia

Por Papadantonakis, Nikolaos, Advani, Anjali S.
Publicado no Ther Adv Hematol (2016)

Management of older adults with acute lymphoblastic leukemia: challenges & current approaches

Por Sawalha, Yazeed, Advani, Anjali S
Publicado no Int J Hematol Oncol (2018)

Adult acute lymphocytic leukemia biology and treatment /

Por Advani, Anjali S., Lazarus, Hillard M.
Publicado em 2011

Navigating the nexus of MRD and novel agents in ALL

Por Advani, Anjali S., Copelan, Edward A.
Publicado no Hematology Am Soc Hematol Educ Program (2019)

Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia

Por Portell, Craig A, Wenzell, Candice M, Advani, Anjali S
Publicado em 2013

Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukeaemia (OPAL): a randomized open-label phase 2 study

Por Cortes, Jorge, Feldman, Eric, Yee, Karen, Rizzieri, David, Advani, Anjali S., Charman, Anthony, Spruyt, Richard, Toal, Martin, Kantarjian, Hagop
Publicado no Lancet Oncol (2013)

Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

Por Sekeres, Mikkael A., Elson, Paul, Kalaycio, Matt E., Advani, Anjali S., Copelan, Edward A., Faderl, Stefan, Kantarjian, Hagop M., Estey, Elihu
Publicado em 2009

SWOG0919: A Phase 2 Study of Idarubicin and Cytarabine in Combination with Pravastatin for Relapsed Acute Myeloid Leukaemia

Por Advani, Anjali S., McDonough, Shannon, Copelan, Edward, Willman, Cheryl, Mulford, Deborah A., List, Alan F., Sekeres, Mikkael A., Othus, Megan, Appelbaum, Frederick R.
Publicado em 2014

Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

Por Advani, Anjali S, Gibson, Sarah E, Douglas, Elizabeth, Jin, Tao, Zhao, Xiaoxian, Kalaycio, Matt, Copelan, Ed, Sobecks, Ronald, Sekeres, Mikkael, Sungren, Shawnda, Hsi, Eric D
Publicado em 2010

SWOG S0910: A Phase 2 Trial of Clofarabine/Cytarabine/Epratuzumab for Relapsed/Refractory Acute Lymphocytic Leukaemia

Por Advani, Anjali S., McDonough, Shannon, Coutre, Steven, Wood, Brent, Radich, Jerald, Mims, Martha, O’Donnell, Margaret, Elkins, Stephanie, Becker, Michael, Othus, Megan, Appelbaum, Frederick R.
Publicado em 2014

A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605

Por Sekeres, Mikkael A., Gundacker, Holly, Lancet, Jeffrey, Advani, Anjali, Petersdorf, Stephen, Liesveld, Jane, Mulford, Deborah, Norwood, Tom, Willman, Cheryl L., Appelbaum, Frederick R., List, Alan F.
Publicado em 2011

Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies

Por Statler, Abby, Othus, Megan, Erba, Harry P., Chauncey, Thomas R., Radich, Jerald P., Coutre, Steven, Advani, Anjali, Nand, Sucha, Ravandi, Farhad, Mukherjee, Sudipto, Sekeres, Mikkael A.
Publicado no Blood (2018)

Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline

Por de Haas, Valérie, Ismaila, Nofisat, Advani, Anjali, Arber, Daniel A., Dabney, Raetasha S., Patel-Donnelly, Dipti, Kitlas, Elizabeth, Pieters, Rob, Pui, Ching-Hon, Sweet, Kendra, Zhang, Ling
Publicado no J Clin Oncol (2019)

Report of the Relapsed/Refractory Cohort of SWOG S0919: A Phase 2 Study of Idarubicin and Cytarabine in Combination with Pravastatin for Acute Myelogenous Leukemia (AML)

Por Advani, Anjali S., Li, Hongli, Michaelis, Laura C., Medeiros, Bruno C., Liedtke, Michaela, List, Alan F., O’Dwyer, Kristen, Othus, Megan, Erba, Harry P., Appelbaum, Frederick R.
Publicado no Leuk Res (2018)

P53-INDEPENDENT, NORMAL STEM CELL SPARING EPIGENETIC-DIFFERENTIATION THERAPY FOR MYELOID AND OTHER MALIGNANCIES

Por Saunthararajah, Yogen, Triozzi, Pierre, Rini, Brian, Singh, Arun, Radivoyevitch, Tomas, Sekeres, Mikkael, Advani, Anjali, Tiu, Ramon, Reu, Frederic, Kalaycio, Matt, Copelan, Ed, Hsi, Eric, Lichtin, Alan, Bolwell, Brian
Publicado em 2012

An inherited genetic variant in CEP72 promoter predisposes to vincristine-induced peripheral neuropathy in adults with acute lymphoblastic leukemia

Por Stock, Wendy, Diouf, Barthelemy, Crews, Kristine R., Pei, Deqing, Cheng, Cheng, Laumann, Kristina, Mandrekar, Sumithra J., Luger, Selina, Advani, Anjali, Stone, Richard M., Larson, Richard A., Evans, William E.
Publicado no Clin Pharmacol Ther (2016)

Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms

Por Visconte, Valeria, Przychodzen, Bartlomiej, Han, Yingchun, Nawrocki, Steffan T., Thota, Swapna, Kelly, Kevin R., Patel, Bhumika J., Hirsch, Cassandra, Advani, Anjali S., Carraway, Hetty E., Sekeres, Mikkael A., Maciejewski, Jaroslaw P., Carew, Jennifer S.
Publicado no Leukemia (2016)

A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia

Por Kantarjian, Hagop M., Schuster, Michael W., Jain, Nitin, Advani, Anjali, Jabbour, Elias, Gamelin, Erick, Rasmussen, Erik, Juan, Gloria, Anderson, Abraham, Chow, Vincent F., Friberg, Gregory, Vogl, Florian D., Sekeres, Mikkael A.
Publicado no Am J Hematol (2017)

The novel autophagy inhibitor ROC-325 augments the anti-leukemic activity of azacitidine

Por Nawrocki, Steffan T., Han, Yingchun, Visconte, Valeria, Przychodzen, Bartlomiej, Espitia, Claudia M., Phillips, James, Anwer, Faiz, Advani, Anjali, Carraway, Hetty E., Kelly, Kevin R., Sekeres, Mikkael A., Maciejewski, Jaroslaw P., Carew, Jennifer S.
Publicado no Leukemia (2019)

Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia

Por Afable, Manuel G., Shaik, Mohammed, Sugimoto, Yuka, Elson, Paul, Clemente, Michael, Makishima, Hideki, Sekeres, Mikkael A., Lichtin, Alan, Advani, Anjali, Kalaycio, Matt, Tiu, Ramon V., O’Keefe, Christine L., Maciejewski, Jaroslaw P.
Publicado em 2011